Rheumatology
The clinical research activity is centered on rheumatoid arthritis, with attention to structural joint damage and disease-related bone changes.
- Rheumatoid arthritis
- Joint erosions
- Inflammatory arthritis
Research interest includes the assessment of erosive changes in affected joints and the evolution of bone lesions over time in patients receiving targeted biologic therapy.
Musculoskeletal Imaging
The sponsor’s trial activity involves advanced imaging of bone and joint structures, with a focus on precise measurement of erosive damage in rheumatoid arthritis.
- High-resolution peripheral quantitative computed tomography
- Bone erosion assessment
- Structural joint evaluation
This area reflects interest in imaging-based monitoring of skeletal involvement and changes in bone integrity within inflammatory disease.
Biologic Therapy
Clinical research includes treatment with tocilizumab, a targeted agent used in autoimmune disease management, with emphasis on its relationship to bone and joint outcomes.
- Tocilizumab
- Subcutaneous administration
- Interleukin-6 pathway
Interest extends to how biologic treatment may influence the progression of erosive lesions in chronic inflammatory arthritis.
